COVID-19 and the Heart: Lessons Learned and Future Research Directions
Abstract
:1. Introduction
2. COVID-19 and the Heart: Lessons Learned
3. COVID-19 and the Heart: Future Directions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef] [PubMed]
- Li, B.; Yang, J.; Zhao, F.; Zhi, L.; Wang, X.; Liu, L.; Bi, Z.; Zhao, Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 2020, 109, 531–538. [Google Scholar] [CrossRef] [PubMed]
- Shi, S.; Qin, M.; Shen, B.; Cai, Y.; Liu, T.; Yang, F.; Gong, W.; Liu, X.; Liang, J.; Zhao, Q. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020, 5, 802–810. [Google Scholar] [CrossRef] [PubMed]
- Hamer, M.; Gale, C.R.; Kivimäki, M.; Batty, G.D. Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom. Proc. Natl. Acad. Sci. USA 2020, 117, 21011–21013. [Google Scholar] [CrossRef] [PubMed]
- Ronderos Botero, D.M.; Omar, A.M.S.; Sun, H.K.; Mantri, N.; Fortuzi, K.; Choi, Y.; Adrish, M.; Nicu, M.; Bella, J.N.; Chilimuri, S. COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes. Arterioscler. Thromb. Vasc. Biol. 2020, 40, 2764–2775. [Google Scholar] [CrossRef] [PubMed]
- Zheng, Y.Y.; Ma, Y.T.; Zhang, J.Y.; Xie, X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020, 17, 259–260. [Google Scholar] [CrossRef]
- Giustino, G.; Croft, L.B.; Stefanini, G.G.; Bragato, R.; Silbiger, J.J.; Vicenzi, M.; Danilov, T.; Kukar, N.; Shaban, N.; Kini, A.; et al. Characterization of Myocardial Injury in Patients with COVID-19. J. Am. Coll. Cardiol. 2020, 76, 2043–2055. [Google Scholar] [CrossRef] [PubMed]
- De la Cruz, A.; Ashraf, S.; Vittorio, T.J.; Bella, J.N. COVID-19 and renin-angiotensin system modulators: What do we know so far? Expert Rev. Cardiovasc. Ther. 2020, 18, 743–748. [Google Scholar] [CrossRef]
- Woodruff, R.C.; Garg, S.; George, M.G.; Patel, K.; Jackson, S.L.; Loustalot, F.; Wortham, J.M.; Taylor, C.A.; Whitaker, M.; Reingold, A.; et al. Acute Cardiac Events During COVID-19-Associated Hospitalizations. J. Am. Coll. Cardiol. 2023, 81, 557–569. [Google Scholar] [CrossRef]
- Williamson, E.J.; Walker, A.J.; Bhaskaran, K.; Bacon, S.; Bates, C.; Morton, C.E.; Curtis, H.J.; Mehrkar, A.; Evans, D.; Inglesby, P.; et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020, 584, 430–436. [Google Scholar] [CrossRef]
- Figliozzi, S.; Masci, P.G.; Ahmadi, N.; Tondi, L.; Koutli, E.; Aimo, A.; Stamatelopoulos, K.; Dimopoulos, M.A.; Caforio, A.L.P.; Georgiopoulos, G. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur. J. Clin. Investig. 2020, 50, e13362. [Google Scholar] [CrossRef] [PubMed]
- Smilowitz, N.R.; Jethani, N.; Chen, J.; Aphinyanaphongs, Y.; Zhang, R.; Dogra, S.; Alviar, C.L.; Keller, N.; Razzouk, L.; Quinones-Camacho, A.; et al. Myocardial Injury in Adults Hospitalized with COVID-19. Circulation 2020, 142, 2393–2395. [Google Scholar] [CrossRef] [PubMed]
- Bikdeli, B.; Madhavan, M.V.; Jimenez, D.; Chuich, T.; Dreyfus, I.; Driggin, E.; Nigoghossian, C.; Ageno, W.; Madjid, M.; Guo, Y.; et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020, 75, 2950–2973. [Google Scholar] [CrossRef] [PubMed]
- Bergamaschi, L.; Mescia, F.; Turner, L.; Hanson, A.L.; Kotagiri, P.; Dunmore, B.J.; Ruffieux, H.; De Sa, A.; Huhn, O.; Morgan, M.D.; et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 2021, 54, 1257–1275.e1258. [Google Scholar] [CrossRef] [PubMed]
- The Lancet, H. COVID-19 coagulopathy: An evolving story. Lancet Haematol. 2020, 7, e425. [Google Scholar] [CrossRef] [PubMed]
- Ackermann, M.; Anders, H.J.; Bilyy, R.; Bowlin, G.L.; Daniel, C.; De Lorenzo, R.; Egeblad, M.; Henneck, T.; Hidalgo, A.; Hoffmann, M.; et al. Patients with COVID-19: In the dark-NETs of neutrophils. Cell Death Differ. 2021, 28, 3125–3139. [Google Scholar] [CrossRef] [PubMed]
- Colling, M.E.; Tourdot, B.E.; Kanthi, Y. Inflammation, Infection and Venous Thromboembolism. Circ. Res. 2021, 128, 2017–2036. [Google Scholar] [CrossRef] [PubMed]
- Giustino, G.; Pinney, S.P.; Lala, A.; Reddy, V.Y.; Johnston-Cox, H.A.; Mechanick, J.I.; Halperin, J.L.; Fuster, V. Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar. J. Am. Coll. Cardiol. 2020, 76, 2011–2023. [Google Scholar] [CrossRef]
- Johnson, J.E.; McGuone, D.; Xu, M.L.; Jane-Wit, D.; Mitchell, R.N.; Libby, P.; Pober, J.S. Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis: Correlation with Neutrophil but Not Endothelial Activation. Am. J. Pathol. 2022, 192, 112–120. [Google Scholar] [CrossRef]
- Wang, J.; Kotagiri, P.; Lyons, P.A.; Al-Lamki, R.S.; Mescia, F.; Bergamaschi, L.; Turner, L.; Morgan, M.D.; Calero-Nieto, F.J.; Bach, K.; et al. Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19. iScience 2022, 25, 103971. [Google Scholar] [CrossRef]
- Ronderos Botero, D.M.; Omar, A.M.S.; Nicu, M.; Sklyar, E.; Bella, J.N.; Chilimuri, S. Anticoagulation for hypercoagulability in severe critical COVID-19: A case series of fading and fatal cycles of microthrombosis. J. Cardiol. Cases 2021, 24, 218–222. [Google Scholar] [CrossRef] [PubMed]
- Comer, S.P.; Cullivan, S.; Szklanna, P.B.; Weiss, L.; Cullen, S.; Kelliher, S.; Smolenski, A.; Murphy, C.; Altaie, H.; Curran, J.; et al. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol. 2021, 19, e3001109. [Google Scholar] [CrossRef] [PubMed]
- Pellegrini, D.; Kawakami, R.; Guagliumi, G.; Sakamoto, A.; Kawai, K.; Gianatti, A.; Nasr, A.; Kutys, R.; Guo, L.; Cornelissen, A.; et al. Microthrombi as a Major Cause of Cardiac Injury in COVID-19. Circulation 2021, 143, 1031–1042. [Google Scholar] [CrossRef] [PubMed]
- Santoro, L.; Zaccone, V.; Falsetti, L.; Ruggieri, V.; Danese, M.; Miro, C.; Di Giorgio, A.; Nesci, A.; D’Alessandro, A.; Moroncini, G.; et al. Role of Endothelium in Cardiovascular Sequelae of Long COVID. Biomedicines 2023, 11, 2239. [Google Scholar] [CrossRef] [PubMed]
- Pollack, A.; Kontorovich, A.R.; Fuster, V.; Dec, G.W. Viral myocarditis—Diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015, 12, 670–680. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.W.; Belin de Chantemèle, E.J.; Weintraub, N.L. Perivascular adipocytes in vascular disease. Arterioscler. Thromb. Vasc. Biol. 2019, 39, 2220–2227. [Google Scholar] [CrossRef] [PubMed]
- Raman, B.; Bluemke, D.A.; Lüscher, T.F.; Neubauer, S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022, 43, 1157–1172. [Google Scholar] [CrossRef]
- Kirkpatrick, J.N.; Swaminathan, M.; Adedipe, A.; Garcia-Sayan, E.; Hung, J.; Kelly, N.; Kort, S.; Nagueh, S.; Poh, K.K.; Sarwal, A.; et al. American Society of Echocardiography COVID-19 Statement Update: Lessons Learned and Preparation for Future Pandemics. J. Am. Soc. Echocardiogr. 2023, 36, 1127–1139. [Google Scholar] [CrossRef]
- Dweck, M.R.; Bularga, A.; Hahn, R.T.; Bing, R.; Lee, K.K.; Chapman, A.R.; White, A.; Salvo, G.D.; Sade, L.E.; Pearce, K.; et al. Global evaluation of echocardiography in patients with COVID-19. Eur. Heart J. Cardiovasc. Imaging 2020, 21, 949–958. [Google Scholar] [CrossRef]
- Karagodin, I.; Carvalho Singulane, C.; Woodward, G.M.; Xie, M.; Tucay, E.S.; Tude Rodrigues, A.C.; Vasquez-Ortiz, Z.Y.; Alizadehasl, A.; Monaghan, M.J.; Ordonez Salazar, B.A.; et al. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J. Am. Soc. Echocardiogr. 2021, 34, 819–830. [Google Scholar] [CrossRef]
- Szekely, Y.; Lichter, Y.; Taieb, P.; Banai, A.; Hochstadt, A.; Merdler, I.; Gal Oz, A.; Rothschild, E.; Baruch, G.; Peri, Y.; et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation 2020, 142, 342–353. [Google Scholar] [CrossRef]
- Okura, H. Update of takotsubo syndrome in the era of COVID-19. J. Cardiol. 2021, 77, 361–369. [Google Scholar] [CrossRef] [PubMed]
- Boehmer, T.K.; Kompaniyets, L.; Lavery, A.M.; Hsu, J.; Ko, J.Y.; Yusuf, H.; Romano, S.D.; Gundlapalli, A.V.; Oster, M.E.; Harris, A.M. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data—United States, March 2020–January 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 1228–1232. [Google Scholar] [CrossRef]
- Gaitonde, M.; Ziebell, D.; Kelleman, M.S.; Cox, D.E.; Lipinski, J.; Border, W.L.; Sachdeva, R. COVID-19-Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease. J. Am. Soc. Echocardiogr. 2020, 33, 1285–1287. [Google Scholar] [CrossRef] [PubMed]
- Chung, M.K.; Zidar, D.A.; Bristow, M.R.; Cameron, S.J.; Chan, T.; Harding, C.V., 3rd; Kwon, D.H.; Singh, T.; Tilton, J.C.; Tsai, E.J.; et al. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ. Res. 2021, 128, 1214–1236. [Google Scholar] [CrossRef]
- Omar, A.M.S.; Hernandez, N.; Ronderos Botero, D.M.; Delacruz, A.; Doppalapudi, S.; Itare, V.; Shin, D.; Mahasamudram, J.; Pandey, N.; Allena, N.; et al. Association between right ventricular dysfunction and in-hospital mortality in surges of SARS-CoV-2 infection attributed to the Alpha, Delta, and Omicron variants. Int. J. Cardiol. Heart Vasc. 2022, 43, 101150. [Google Scholar] [CrossRef] [PubMed]
- Alam, L.; Omar, A.M.S.; Talebi, S.; Narula, J.; Argulian, E. Echocardiographic Findings in Patients with COVID-19 with Myocardial Injury During the Omicron Variant Surge. Am. J. Cardiol. 2022, 172, 168–169. [Google Scholar] [CrossRef] [PubMed]
- D’Alto, M.; Marra, A.M.; Severino, S.; Salzano, A.; Romeo, E.; De Rosa, R.; Stagnaro, F.M.; Pagnano, G.; Verde, R.; Murino, P.; et al. Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS. Crit. Care 2020, 24, 670. [Google Scholar] [CrossRef]
- Creel-Bulos, C.; Hockstein, M.; Amin, N.; Melhem, S.; Truong, A.; Sharifpour, M. Acute Cor Pulmonale in Critically Ill Patients with COVID-19. N. Engl. J. Med. 2020, 382, e70. [Google Scholar] [CrossRef]
- Cavaleiro, P.; Masi, P.; Bagate, F.; d’Humières, T.; Mekontso Dessap, A. Acute cor pulmonale in COVID-19 related acute respiratory distress syndrome. Crit. Care 2021, 25, 346. [Google Scholar] [CrossRef]
- Poissy, J.; Goutay, J.; Caplan, M.; Parmentier, E.; Duburcq, T.; Lassalle, F.; Jeanpierre, E.; Rauch, A.; Labreuche, J.; Susen, S.; et al. Pulmonary Embolism in Patients with COVID-19. Circulation 2020, 142, 184–186. [Google Scholar] [CrossRef] [PubMed]
- Adaani, F.; David, B.; Gibbs, J.S.R.; Deepa, G.; Dinesh, K.; Alessandra, M.; Ronald, O.; Toru, S.; Fernando, T.; Adam, T. Diagnosis of pulmonary hypertension. Eur. Respir. J. 2019, 53, 1801904. [Google Scholar] [CrossRef]
- Xie, Y.; Xu, E.; Bowe, B.; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022, 28, 583–590. [Google Scholar] [CrossRef] [PubMed]
- Davis, H.E.; McCorkell, L.; Vogel, J.M.; Topol, E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023, 21, 133–146. [Google Scholar] [CrossRef] [PubMed]
- Carfì, A.; Bernabei, R.; Landi, F. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020, 324, 603–605. [Google Scholar] [CrossRef] [PubMed]
- Department of Health and Human Services USA (Ed.) National Research Action Plan on Long COVID; Department of Health and Human Services USA: Washington, DC, USA, 2022. [Google Scholar]
- Daniel, A.; Kamlesh, K.; Vahé, N.; Thomas, M.; Ben, H.; Ian, D.; Amitava, B. Post-COVID syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study. BMJ 2021, 372, n693. [Google Scholar] [CrossRef]
- Andrea, D.; Malgorzata, W.; Johann, A.; Jude, O.; Daniel, J.C.; Dan, W.; Michael, C.; Mark, G.; Michael, B.; Lyth, H.; et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open 2021, 11, e048391. [Google Scholar] [CrossRef]
- Wong, A.C.; Devason, A.S.; Umana, I.C.; Cox, T.O.; Dohnalova, L.; Litichevskiy, L.; Perla, J.; Lundgren, P.; Etwebi, Z.; Izzo, L.T.; et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 2023, 186, 4851–4867.e20. [Google Scholar] [CrossRef]
- VanElzakker, M.B. Chronic fatigue syndrome from vagus nerve infection: A psychoneuroimmunological hypothesis. Med. Hypotheses 2013, 81, 414–423. [Google Scholar] [CrossRef]
- Nalbandian, A.; Sehgal, K.; Gupta, A.; Madhavan, M.V.; McGroder, C.; Stevens, J.S.; Cook, J.R.; Nordvig, A.S.; Shalev, D.; Sehrawat, T.S.; et al. Post-acute COVID-19 syndrome. Nat. Med. 2021, 27, 601–615. [Google Scholar] [CrossRef]
- Rossi, R.; Coppi, F.; Monopoli, D.E.; Sgura, F.A.; Arrotti, S.; Boriani, G. Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors. Cardiol. J. 2022, 29, 163–165. [Google Scholar] [CrossRef] [PubMed]
- Puntmann, V.O.; Carerj, M.L.; Wieters, I.; Fahim, M.; Arendt, C.; Hoffmann, J.; Shchendrygina, A.; Escher, F.; Vasa-Nicotera, M.; Zeiher, A.M.; et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020, 5, 1265–1273. [Google Scholar] [CrossRef] [PubMed]
- Rajpal, S.; Tong, M.S.; Borchers, J.; Zareba, K.M.; Obarski, T.P.; Simonetti, O.P.; Daniels, C.J. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021, 6, 116–118. [Google Scholar] [CrossRef] [PubMed]
- Karagodin, I.; Singulane, C.C.; Descamps, T.; Woodward, G.M.; Xie, M.; Tucay, E.S.; Sarwar, R.; Vasquez-Ortiz, Z.Y.; Alizadehasl, A.; Monaghan, M.J.; et al. Ventricular Changes in Patients with Acute COVID-19 Infection: Follow-up of the World Alliance Societies of Echocardiography (WASE-COVID) Study. J. Am. Soc. Echocardiogr. 2022, 35, 295–304. [Google Scholar] [CrossRef] [PubMed]
- Szekely, Y.; Lichter, Y.; Sadon, S.; Lupu, L.; Taieb, P.; Banai, A.; Sapir, O.; Granot, Y.; Hochstadt, A.; Friedman, S.; et al. Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019. J. Am. Soc. Echocardiogr. 2021, 34, 1273–1284.e1279. [Google Scholar] [CrossRef] [PubMed]
- Chaturvedi, H.; Issac, R.; Sharma, S.K.; Gupta, R. Progressive left and right heart dysfunction in coronavirus disease-19: Prospective echocardiographic evaluation. Eur. Heart J. Cardiovasc. Imaging 2022, 23, 319–325. [Google Scholar] [CrossRef] [PubMed]
- Watson, O.J.; Barnsley, G.; Toor, J.; Hogan, A.B.; Winskill, P.; Ghani, A.C. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect. Dis. 2022, 22, 1293–1302. [Google Scholar] [CrossRef] [PubMed]
- Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2020, 384, 403–416. [Google Scholar] [CrossRef]
- Ingul, C.B.; Grimsmo, J.; Mecinaj, A.; Trebinjac, D.; Berger Nossen, M.; Andrup, S.; Grenne, B.; Dalen, H.; Einvik, G.; Stavem, K.; et al. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19. J. Am. Heart Assoc. 2022, 11, e023473. [Google Scholar] [CrossRef]
- Jiang, J.; Chan, L.; Kauffman, J.; Narula, J.; Charney, A.W.; Oh, W.; Nadkarni, G.; Consortium, N.C. Impact of Vaccination on Major Adverse Cardiovascular Events in Patients with COVID-19 Infection. J. Am. Coll. Cardiol. 2023, 81, 928–930. [Google Scholar] [CrossRef]
- Johnson, K.W.; Patel, S.; Thapi, S.; Jaladanki, S.K.; Rao, A.; Nirenberg, S.; Lala, A. Association of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients with Heart Failure. J. Card. Fail. 2022, 28, 1475–1479. [Google Scholar] [CrossRef] [PubMed]
- Juthani, P.V.; Gupta, A.; Borges, K.A.; Price, C.C.; Lee, A.I.; Won, C.H.; Chun, H.J. Hospitalisation among vaccine breakthrough COVID-19 infections. Lancet Infect. Dis. 2021, 21, 1485–1486. [Google Scholar] [CrossRef] [PubMed]
- Nixon, D.F.; Ndhlovu, L.C. Vaccine breakthrough infections with SARS-CoV-2 variants. N. Engl. J. Med. 2021, 385, e7. [Google Scholar] [CrossRef] [PubMed]
- Al-Aly, Z.; Bowe, B.; Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022, 28, 1461–1467. [Google Scholar] [CrossRef] [PubMed]
- The Task Force for the Management of COVID-19 of the European Society of Cardiology. ESC Guidance for the Diagnosis and Management of Cardiovascular Disease during the COVID-19 Pandemic: Part 2—Care Pathways, Treatment, and Follow-Up. Eur. Heart J. 2022, 43, 1059–1103. [Google Scholar] [CrossRef] [PubMed]
- Duffy, E.; Chilazi, M.; Cainzos-Achirica, M.; Michos, E.D. Cardiovascular Disease Prevention During the COVID-19 Pandemic: Lessons Learned and Future Opportunities. Methodist Debakey Cardiovasc. J. 2021, 17, 68–78. [Google Scholar] [CrossRef] [PubMed]
- Writing, C.; Gluckman, T.J.; Bhave, N.M.; Allen, L.A.; Chung, E.H.; Spatz, E.S.; Ammirati, E.; Baggish, A.L.; Bozkurt, B.; Cornwell, W.K., 3rd; et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2022, 79, 1717–1756. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, T.C.-C.; Omar, A.M.S.; Bella, J.N. COVID-19 and the Heart: Lessons Learned and Future Research Directions. Cardiogenetics 2024, 14, 51-58. https://doi.org/10.3390/cardiogenetics14010004
Lee TC-C, Omar AMS, Bella JN. COVID-19 and the Heart: Lessons Learned and Future Research Directions. Cardiogenetics. 2024; 14(1):51-58. https://doi.org/10.3390/cardiogenetics14010004
Chicago/Turabian StyleLee, Tetz Cheng-Che, Alaa Mabrouk Salem Omar, and Jonathan N. Bella. 2024. "COVID-19 and the Heart: Lessons Learned and Future Research Directions" Cardiogenetics 14, no. 1: 51-58. https://doi.org/10.3390/cardiogenetics14010004
APA StyleLee, T. C. -C., Omar, A. M. S., & Bella, J. N. (2024). COVID-19 and the Heart: Lessons Learned and Future Research Directions. Cardiogenetics, 14(1), 51-58. https://doi.org/10.3390/cardiogenetics14010004